A health worker gets ready to collect samples during proactive testing of migrant workers at their work place, amid the spread of the coronavirus disease (COVID-19) outbreak in Samut Sakhon province in Thailand. (REUTERS)
A health worker gets ready to collect samples during proactive testing of migrant workers at their work place, amid the spread of the coronavirus disease (COVID-19) outbreak in Samut Sakhon province in Thailand. (REUTERS)

Chinese Covid-19 vaccine Sinovac gets local emergency use in Thailand

Thailand’s Food and Drug Administration has approved Sinovac Biotech Ltd.’s Covid-19 vaccine for local emergency use ahead of the launch of a national inoculation program.
Bloomberg
UPDATED ON FEB 23, 2021 12:59 PM IST

Thailand’s Food and Drug Administration has approved Sinovac Biotech Ltd.’s Covid-19 vaccine for local emergency use ahead of the launch of a national inoculation program.

Thai FDA Secretary-General Paisarn Dunkum signed the emergency use approval on Monday ahead of the arrival of the first batch of 2 million doses of Sinovac shots ordered by Thailand on Wednesday. The authorization for Sinovac’s jabs is valid for one year, according to the approval letter by the drug regulator.

Thailand, which aims to inoculate 50% of its population by the end of this year, has already approved AstraZeneca Plc’s Covid-19 vaccine for emergency use. The Southeast Asian nation has ordered 61 million doses of AstraZeneca vaccine, which will be produced locally by Siam Bioscience Ltd. through technology transfer.

SHARE THIS ARTICLE ON
Close
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)
A study by the University of Oxford shows AstraZeneca effective against Brazil variant.(AP)

Covid-19 pandemic: WHO warns against letting guard down

Agencies, Geneva
UPDATED ON MAR 07, 2021 05:37 AM IST
“Countries are going to lurch back into third and fourth surges if we’re not careful.” Mike Ryan, WHO’s top emergency expert, told an online briefing.
Close
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)
In the second phase of the vaccination drive, 3,005,039 people over 60 years of age and 460,782 between 45 and 59 years with comorbidities have received their first dose of the vaccine.(Reuters)

Cumulative Covid-19 vaccinations cross 20-million mark: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 06, 2021 11:35 PM IST
India has administered 20,662,073 doses of the vaccine so far of which 6,972,859 healthcare workers have received the first dose and 3,522,671 have got the second dose.
Close
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)
Indian Army personnel receives a dose of COVID-19 vaccine at a military hospital in Jabalpur. (PTI Photo)

Army veterans to be vaccinated from next week. All you need to know

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
PUBLISHED ON MAR 06, 2021 11:28 PM IST
  • The government, when it launched its vaccination programme on January 16, ensured that army personnel involved in active duty also get vaccinated as the nation in its first phase had decided to inoculate healthcare workers as well as frontline workers.
Close
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)
Researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.(Reuters)

Study says some coronavirus mutations help it evade T-killer cells

PTI, London
UPDATED ON MAR 06, 2021 04:22 PM IST
In the current study, published in the journal Cell Immunology, the researchers sequenced 750 genomes of the novel coronavirus from infected individuals and analysed mutations for their potential to alter T cell epitopes.
Close
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)
The researchers at the Georgia Institute of Technology and Emory University, US, used the technology to code for a protein called Cas13a that destroys parts of the RNA genetic code which viruses use to replicate in cells in the lungs.(HT Archive/For Representative Purposes Only)

Treatment based on CRISPR can stop replication of Covid-19, flu viruses: Study

PTI, Washington
PUBLISHED ON MAR 05, 2021 04:34 PM IST
The therapy, described in the journal Nature Biotechnology, is based on CRISPR technology, which is normally used to target and edit specific portions of the genetic code -- the way that the four bases of DNA -- A, C, G and T -- are strung together.
Close
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)
The study is the world's largest trial of treatments for hospitalised Covid-19 adults.(Reuters file photo. Representative image)

UK Covid-19 trial finds no benefit of gout drug in hospitalised adults

Posted by Harshit Sabarwal | Reuters
PUBLISHED ON MAR 05, 2021 04:06 PM IST
An independent panel suggested pausing recruitment of volunteers in the colchicine arm of the trial based on a preliminary analysis, scientists involved in UK's RECOVERY study said.
Close
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)
The researchers said there is wide variation in how much antibody a person produces in response to vaccination or natural infection.(AP)

Covid-19 antibodies, vaccines less effective against virus variants: Study

Posted by Harshit Sabarwal | PTI, Washington
PUBLISHED ON MAR 05, 2021 02:33 PM IST
The research, published in the journal Nature Medicine, noted that the three fast-spreading variants of the coronavirus first reported in South Africa, the UK and Brazil, can evade antibodies that work against the original form of the virus that sparked the pandemic.
Close
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)
India’s vaccination drive has completed 17,711,287 jabs as of 7pm on Thursday.(HT Photo)

More than 1 million Covid-19 vaccine doses given in a day: Government

By hindustantimes.com | Written by Srivatsan K C, New Delhi
PUBLISHED ON MAR 04, 2021 11:16 PM IST
“Total 10,93,954 vaccine doses were given till 7 pm today, the forty-eighth day of nationwide COVID19 vaccination,” the health ministry said in a statement.
Close
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)
South Africa regulator at 'advanced' stage of Pfizer's Covid-19 vaccine review (Reuters)

South Africa regulator at 'advanced' stage of Pfizer Covid-19 vaccine review

Reuters
PUBLISHED ON MAR 04, 2021 10:46 PM IST
According to the South African Health Products Regulatory Authority (SAHPRA), Pfizer's Section 21 application is in advanced stages of review. Such an application, normally valid for six months, is an instrument for emergency use access of a health product that is unregistered.
Close
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)
The isolates or viral samples were recovered from nasal secretions of consenting Covid-19 positive individuals.(Pixabay | Representational image)

Indian study finds multiple mutations, unique proteins in coronavirus

PTI, Bengaluru
PUBLISHED ON MAR 04, 2021 04:36 PM IST
The study has also shown that the host produces several proteins of their own as their body launches an immunological defence in response to the viral attack.
Close
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)
Canadian company Resverlogix has used the QIMR Berghofer research findings as the basis for expanding its clinical trial of the drug, apabetalone.(Representative image/Bloomberg)

Researchers identify cause, potential treatment for Covid-induced heart damage

ANI, Washington
PUBLISHED ON MAR 04, 2021 05:09 AM IST
In severe cases of Covid-19, the immune system overreacts to the infection, releasing inflammatory molecules called cytokines into the bloodstream.
Close
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)
Terezinha da Conceicao, 80, left, and Dulcinea da Silva Lopes, 59, get vaccinated in front of the Christ the Redeemer statue in Rio de Janeiro, Brazil. Data in recent weeks on new variants from South Africa and Brazil has undercut optimism sparked late last year by two vaccines with around 95% efficacy against Covid-19. (AP Photo)

Mutating Covid-19 mars optimism initially brought on by vaccines: Report

Reuters, Chicago
PUBLISHED ON MAR 03, 2021 11:12 PM IST
A new consensus is emerging among scientists, according to Reuters interviews with 18 specialists who closely track the pandemic or are working to curb its impact.
Close
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)
PM Modi, President Kovind, Vice President Naidu, Union minister Harsh Vardhan and eminent Sarod player Ustad Amjad Ali Khan received their first does of Covid-19 vaccine. (HT Photos/Twitter/BeFunkyCollage)

Covid-19 vaccination drive: List of eminent personalities inoculated

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 08:10 PM IST
  • These lawmakers are trying to address vaccine hesitancy which medical experts and lawmakers believe may impact the vaccination drive.
Close
Representational image. (Pratham Gokhale/HT Photo)
Representational image. (Pratham Gokhale/HT Photo)

Covaxin shows 81% efficacy in phase 3 clinical trial: Bharat Biotech

UPDATED ON MAR 04, 2021 03:44 AM IST
The vaccine is stable at 2°C to 8°C (refrigeration) and is shipped in a ready-to-use liquid formulation that permits distribution using existing vaccine supply chain channels
Close
A health worker holding up a Covaxin Covid-19 vaccine vial at Delhi Heart and Lung Institute in New Delhi. (Amal KS/ Hindustan Times)
A health worker holding up a Covaxin Covid-19 vaccine vial at Delhi Heart and Lung Institute in New Delhi. (Amal KS/ Hindustan Times)

Bharat Biotech releases Phase 3 results, says Covaxin has 81% efficacy rate

By hindustantimes.com | Edited by Shankhyaneel Sarkar, Hindustan Times, New Delhi
UPDATED ON MAR 03, 2021 07:53 PM IST
  • Interim clinical efficacy of India-made Covaxin is 81%, says Bharat Biotech
Close
SHARE
Story Saved
OPEN APP